Literature DB >> 3788967

Modification of experimental aminoglycoside nephrotoxicity.

W M Bennett, C A Wood, D C Houghton, D N Gilbert.   

Abstract

Some of the factors that modify experimental aminoglycoside nephrotoxicity are reviewed. Maneuvers ready to be tested for effectiveness in the clinical use of these drugs are highlighted. The use of concomitant penicillins and changes in dosing strategy seem to be particularly exciting new leads toward elimination of clinical aminoglycoside nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3788967     DOI: 10.1016/s0272-6386(86)80100-7

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  6 in total

1.  Once-daily aminoglycoside dosing: A new look at an old drug.

Authors:  J Conly; W Gold; S Shafran
Journal:  Can J Infect Dis       Date:  1994-09

Review 2.  Once-daily aminoglycoside therapy.

Authors:  D N Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

Review 3.  Drug-induced nephrotoxicity. Aetiology, clinical features and management.

Authors:  A J Hoitsma; J F Wetzels; R A Koene
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

4.  Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of gram-negative pyelonephritis in children.

Authors:  A Viganò; N Principi; L Brivio; P Tommasi; P Stasi; A D Villa
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

Review 5.  Nephrotoxic drugs.

Authors:  S A Mendoza
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

Review 6.  The role of medications and their management in acute kidney injury.

Authors:  Bradford L McDaniel; Michael L Bentley
Journal:  Integr Pharm Res Pract       Date:  2015-05-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.